Study Announcement for Advanced Cancer and Liver Dysfunction
Share
Follow Us
Summary: PHI-50 NCI#6432: A Phase I Pharmacokinetic Study of PS-341 in Patients with Advanced Malignancies and Varying Degrees of Liver Dysfunction for the CTEP-Sponsored Organ Dysfunction Working Group
You have been asked to participate in this research study because you have advanced cancer that is no longer responding to standard treatment and your liver function is normal or is no longer normal. The purpose of this research study is to find out the highest dose of an experimental drug PS-341 that can be given to subjects with advanced cancer and abnormal liver function without causing unmanageable side effects. Additionally, researchers will be looking to find out how the study drug moves through the body.
Patient Inclusion/Exclusion Criteria:
– See http://clinicaltrials.coh.org for additional information.
Contact:
City of Hope National Medical Center
1500 East Duarte Road
Duarte, CA 91010-3000
Telephone: 866-896-HOPE (4673)
Source: www.centerwatch.com
